Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hope

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Jac-Antimicrobial Resistance|July 27, 2022
CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapyAlex Howard, William Hope
Expert Opinion on Drug Metabolism & Toxicology|April 26, 2012
Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infectionsJoanne Livermore, William Hope
The Journal of Infection|September 10, 2003
Sequential infection with Nocardia farcinica and Cryptococcus neoformans var. gattii in an immunocompetent hostWilliam Hope, David Looke
Journal of Fungi (Basel, Switzerland)|February 25, 2023
Assessment of Antifungal PharmacodynamicsAlex Howard, William Hope
The Journal of Antimicrobial Chemotherapy|May 31, 2022
Correction to: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing EnterobacteralesChristopher A Darlow, William Hope
The Journal of Antimicrobial Chemotherapy|December 30, 2021
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing EnterobacteralesChristopher A Darlow, William Hope
Expert Opinion on Drug Metabolism & Toxicology|June 27, 2018
Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous systemKatharine E Stott, William Hope
The Journal of Antimicrobial Chemotherapy|March 4, 2022
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' responseChristopher A Darlow, William Hope
The Lancet. Infectious Diseases|February 23, 2023
ChatGPT and antimicrobial advice: the end of the consulting infection doctor?Alex Howard, William Hope, Alessandro Gerada
Journal of the American College of Surgeons|March 13, 2026
It's Not All About Recurrence!Colston Edgerton, Andy Cole, William Hope
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Jac-Antimicrobial Resistance|July 27, 2022
CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapyAlex Howard, William Hope
Expert Opinion on Drug Metabolism & Toxicology|April 26, 2012
Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infectionsJoanne Livermore, William Hope
The Journal of Infection|September 10, 2003
Sequential infection with Nocardia farcinica and Cryptococcus neoformans var. gattii in an immunocompetent hostWilliam Hope, David Looke
Journal of Fungi (Basel, Switzerland)|February 25, 2023
Assessment of Antifungal PharmacodynamicsAlex Howard, William Hope
The Journal of Antimicrobial Chemotherapy|May 31, 2022
Correction to: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing EnterobacteralesChristopher A Darlow, William Hope
The Journal of Antimicrobial Chemotherapy|December 30, 2021
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing EnterobacteralesChristopher A Darlow, William Hope
Expert Opinion on Drug Metabolism & Toxicology|June 27, 2018
Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous systemKatharine E Stott, William Hope
The Journal of Antimicrobial Chemotherapy|March 4, 2022
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' responseChristopher A Darlow, William Hope
The Lancet. Infectious Diseases|February 23, 2023
ChatGPT and antimicrobial advice: the end of the consulting infection doctor?Alex Howard, William Hope, Alessandro Gerada
Journal of the American College of Surgeons|March 13, 2026
It's Not All About Recurrence!Colston Edgerton, Andy Cole, William Hope
Pageof 16